DSE : IBNSINA

The IBN SINA Pharmaceutical Industry PLC — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 293.2 BDT (At close: Oct 29, 2026) · Market cap 9.16B

Latest research: IBN SINA Pharmaceutical financial analysis: 18% 9M sales growth, Mawna plant capex and record 77% dividend (Oct 2026) · IBN SINA Pharmaceutical: 9M FY2026 sales up 18% as the Mawna plant lifts capital work-in-progress to BDT 4.1bn, funded mostly with debt

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap9.16B
Enterprise Value13.01B

Dates

MeasureValue
Earnings DateNov 10, 2026
Ex-Dividend DateOct 27, 2026

Shares

MeasureValue
Current Share Class13.69M
Shares Outstanding31.24M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)0.37%
Owned by Institutions (%)44.31%
Floatn/a

Ratios

MeasureValue
PE Ratio11.53
Forward PEn/a
PS Ratio0.66
PB Ratio1.97
P/TBV Ratio2.03
P/FCF Ration/a
P/OCF Ratio7.73
PEG Ration/a

Evratios

MeasureValue
EV / Earnings16.37
EV / Sales0.94
EV / EBITDA9.92
EV / EBIT11.75
EV / FCFn/a

Financialposition

MeasureValue
Current Ratio0.68
Quick Ratio0.10
Debt / Equity0.86
Debt / EBITDA3.06
Debt / FCFn/a
Interest Coverage8.66

Financialefficiency

MeasureValue
Return on Equity (ROE)18.33%
Return on Assets (ROA)7.54%
Return on Invested Capital (ROIC)10.81%
Return on Capital Employed (ROCE)18.62%
Weighted Average Cost of Capital (WACC)4.47%
Revenue Per Employee2.67M
Profits Per Employee152,814
Employee Count5,200
Asset Turnover1.51
Inventory Turnover4.31

Taxes

MeasureValue
Income Tax221.65M
Effective Tax Rate21.85%

Stockprice

MeasureValue
Beta (5Y)0.20
52-Week Price Change+0.27%
50-Day Moving Average311.67
200-Day Moving Average318.32
Relative Strength Index (RSI)27.78
Average Volume (20 Days)14,960

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue13.90B
Gross Profit5.75B
Operating Income1.11B
Pretax Income1.01B
Net Income794.63M
EBITDA1.31B
EBIT1.11B
Earnings Per Share (EPS)25.43

Balancesheet

MeasureValue
Cash & Cash Equivalents297.31M
Total Debt4.01B
Net Cash-3.71B
Net Cash Per Share-118.71
Equity (Book Value)4.66B
Book Value Per Share144.56
Working Capital-1.56B

Cashflow

MeasureValue
Operating Cash Flow1.19B
Capital Expenditures-3.03B
Depreciation & Amortization204.07M
Net Borrowing1.96B
Free Cash Flow-1.85B
FCF Per Share-59.13

Margins

MeasureValue
Gross Margin41.39%
Operating Margin7.97%
Pretax Margin7.30%
Profit Margin5.72%
EBITDA Margin9.43%
EBIT Margin7.97%
FCF Marginn/a

Dividends

MeasureValue
Dividend Per Share7.70
Dividend Yield2.63%
Dividend Growth (YoY)20.31%
Years of Dividend Growth2
Payout Ratio26.93%
FCF Payout Ration/a
Buyback Yieldn/a
Shareholder Yield2.63%
Earnings Yield8.67%
FCF Yield-20.17%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)16.31%
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split DateOct 23, 2018
Split TypeForward
Split Ratio1.1

Scores

MeasureValue
Altman Z-Scoren/a
Piotroski F-Score5

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside